3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Colorectal Neoplasms
12
Breast Neoplasms
12
Pain
11
Neoplasms
10
Pain, Postoperative
9
Prostatic Neoplasms
7
Lung Neoplasms
6
Agnosia
6
Colonic Neoplasms
5
Neuralgia
4
Keratosis, Actinic
4
Cancer Pain
4
Liver Neoplasms
3
Leiomyoma
3
Head and Neck Neoplasms
3
Chronic Pain
3
Thyroid Neoplasms
2
Stomach Neoplasms
2
Pilonidal Sinus
2
Oropharyngeal Neoplasms
2
Neuroma
2
Neoplasm Metastasis
2
Myofibroma
2
Inflammatory Bowel Diseases
2
Ileus
2
Diverticulitis
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Cisplatin
55
Radiotherapy
33
Cetuximab
25
Paclitaxel
23
Carboplatin
23
Radiotherapy, Intensity-Modulated
21
pembrolizumab
19
Docetaxel
17
Fluorouracil
16
Nivolumab
14
Drug Therapy
11
Radiation
9
Erlotinib Hydrochloride
8
Blood Specimen Collection
8
durvalumab
7
Magnetic Resonance Spectroscopy
7
Surveys and Questionnaires
6
atezolizumab
5
Surgical Procedures, Operative
5
Radiosurgery
5
Esophagectomy
5
Chemoradiotherapy
5
olaparib
4
dacomitinib
4
Leucovorin
4
Cyclophosphamide
4
Capecitabine
4
Biopsy
4
Afatinib
4
fludarabine phosphate
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Squamous Cell
×
Lidocaine
×
Clear all
NCT06747390
2026-05-12
856397
Abramson Cancer Center at Penn Medicine
Phase 1
Recruiting
30 enrolled